Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
4.010
+0.010 (0.25%)
At close: Feb 18, 2026, 4:00 PM EST
4.100
+0.090 (2.24%)
After-hours: Feb 18, 2026, 4:10 PM EST
Shattuck Labs Revenue
Shattuck Labs had revenue of $1.00M in the quarter ending September 30, 2025, a decrease of -66.63%. This brings the company's revenue in the last twelve months to $1.00M, down -84.46% year-over-year. In the year 2024, Shattuck Labs had annual revenue of $5.72M with 245.26% growth.
Revenue (ttm)
$1.00M
Revenue Growth
-84.46%
P/S Ratio
253.75
Revenue / Employee
$22,727
Employees
44
Market Cap
253.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.72M | 4.06M | 245.26% |
| Dec 31, 2023 | 1.66M | 1.01M | 154.14% |
| Dec 31, 2022 | 652.00K | -29.37M | -97.83% |
| Dec 31, 2021 | 30.02M | 20.08M | 202.16% |
| Dec 31, 2020 | 9.93M | 47.00K | 0.48% |
| Dec 31, 2019 | 9.89M | -12.56M | -55.94% |
| Dec 31, 2018 | 22.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Coherus Oncology | 277.73M |
| X4 Pharmaceuticals | 33.98M |
| OmniAb | 21.09M |
| Opus Genetics | 14.63M |
| AC Immune | 5.48M |
| Neurogene | 925.00K |
| Inhibikase Therapeutics | 1.00 |
STTK News
- 12 days ago - Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium - GlobeNewsWire
- 2 months ago - Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Analyst Upgrade Boosts Shattuck On Confidence In Next-Gen Inflammatory Bowel Disease Therapy - Benzinga
- 3 months ago - Shattuck Labs to Participate in Upcoming December Investor Conferences - GlobeNewsWire
- 3 months ago - Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 4 months ago - Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript - Seeking Alpha
- 4 months ago - Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel - GlobeNewsWire
- 6 months ago - Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors - GlobeNewsWire